Literature DB >> 23017626

Activity as a measure of symptom control.

David C Currow, Amy P Abernethy, Miriam J Johnson.   

Abstract

Mesh：

Year:  2012        PMID： 23017626     DOI： 10.1016/j.jpainsymman.2012.07.005

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN： 0885-3924            Impact factor:   3.612


× No keyword cloud information.
  3 in total

1.  The longitudinal pattern of response when morphine is used to treat chronic refractory dyspnea.

Authors:  David C Currow; Stephen Quinn; Aine Greene; Janet Bull; Miriam J Johnson; Amy P Abernethy
Journal:  J Palliat Med       Date:  2013-06-08       Impact factor: 2.947

2.  A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocol.

Authors:  David Currow; Gareth John Watts; Miriam Johnson; Christine F McDonald; John O Miners; Andrew A Somogyi; Linda Denehy; Nicola McCaffrey; Danny J Eckert; Philip McCloud; Sandra Louw; Lawrence Lam; Aine Greene; Belinda Fazekas; Katherine C Clark; Kwun Fong; Meera R Agar; Rohit Joshi; Sharon Kilbreath; Diana Ferreira; Magnus Ekström
Journal:  BMJ Open       Date:  2017-07-17       Impact factor: 2.692

3.  Prospectively collected characteristics of adult patients, their consultations and outcomes as they report breathlessness when presenting to general practice in Australia.

Authors:  David C Currow; Katherine Clark; Geoffrey K Mitchell; Miriam J Johnson; Amy P Abernethy
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.